70% of the patients who achieved SVR in the Telaprevir arms got 24 weeks of total treatment, while 30% of the patients who achieved SVR in the Telaprevir arms got 48 weeks of total treatment. There was no difference between the two Telaprevir arms in this regard.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”